Pantoprazol Stada (Pantoprazole)

Pantoprazole, the active ingredient in Pantoprazol Stada, is a proton pump inhibitor presented as a tablet for oral use. It reduces stomach acid production and is used to treat gastro‑reflux, GERD and related ulcer conditions in adults. GNH USA supplies Pantoprazol Stada as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Pantoprazol Stada belongs to the proton pump inhibitor class and is indicated for conditions involving excess gastric acid secretion. - Gastro‑esophageal reflux disease (GERD): alleviates heartburn and promotes healing of esophageal lining. - Erosive esophagitis: supports regeneration of damaged esophageal tissue. - Zollinger‑Ellison syndrome: controls excessive gastric acid production associated with the disorder.

Pantoprazol Stada may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Headache: mild discomfort often resolving without treatment. - Diarrhea: loose stools that typically improve with continued therapy. - Nausea: occasional feeling of queasiness. - Abdominal pain: mild cramping or discomfort. - Flatulence: increased intestinal gas. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Severe allergic reaction: rash, itching, swelling, or difficulty breathing. - Clostridioides difficile infection: persistent watery diarrhea. - Low magnesium levels: muscle cramps, irregular heartbeat. - Bone fractures: increased risk with long‑term use. - Liver enzyme elevation: signs of hepatic stress. - Acute interstitial nephritis: kidney inflammation presenting with fever and rash.

Before initiating therapy with Pantoprazol Stada, consider the following safety measures: - Assess renal function: adjust use in severe impairment. - Review liver status: use with caution in hepatic disease. - Evaluate need for long‑term therapy: weigh benefits against fracture risk. - Monitor electrolytes: especially magnesium during prolonged treatment. - Avoid abrupt discontinuation: taper to reduce rebound acid hypersecretion. - Store at ambient temperature: keep below 25°C, in original packaging, protected from moisture.

Pantoprazol Stada can affect the pharmacokinetics of several co‑administered medicines. Review the following interaction categories:

Major Interactions (Avoid): - Ketoconazole: reduced absorption due to higher gastric pH. - Atazanavir: markedly decreased plasma concentrations. - Clopidogrel: diminished antiplatelet effect.

Moderate Interactions (Monitor Closely): - Warfarin: potential increase in INR; monitor coagulation. - Digoxin: possible rise in serum levels. - Methotrexate (high dose): decreased renal clearance; check levels.